Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Kura Oncology, Inc. - Common Stock (NQ:KURA)

9.860 -0.300 (-2.95%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,573,210
Open 10.02
Bid (Size) 9.670 (1,000)
Ask (Size) 9.940 (500)
Prev. Close 10.16
Today's Range 9.452 - 10.05
52wk Range 5.410 - 19.73
Shares Outstanding 68,438,576
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Tech's AI Surge Meets Pharma's Resilient Recovery: A Tale of Two Markets in Late 2025
The financial markets as of November 5, 2025, present a compelling dichotomy with the technology and pharmaceutical sectors charting distinct yet largely positive courses. While technology continues... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
Kura Oncology (NASDAQ:KURA) Reports Q3 2025 Revenue Miss But Narrower-Than-Expected Loss
Kura Oncology reported a Q3 2025 revenue miss but a narrower loss. Investors focus on the upcoming FDA decision for its lead drug, ziftomenib, a key catalyst. 
Via Chartmill

Performance

YTD
+13.6%
+13.6%
1 Month
+0.1%
+0.1%
3 Month
+78.0%
+78.0%
6 Month
+61.9%
+61.9%
1 Year
-43.8%
-43.8%

More News

Read More
Earnings Scheduled For November 4, 2025
Via Benzinga
Kura Oncology Scores $30 Million Boost As New Leukemia Drug Enters Major Trial
Via Benzinga
KURA Stock Rises Pre-Market After Receiving Milestone Payment Related To Cancer Drug Development Agreement
Via Stocktwits
Earnings Scheduled For August 7, 2025
Via Benzinga
Earnings Scheduled For May 1, 2025
Via Benzinga
Uncovering Potential: Kura Oncology's Earnings Preview
Via Benzinga
Earnings Scheduled For February 26, 2025
Via Benzinga
Leap Therapeutics (LPTX) Plummets Over 20% Amidst Profit-Taking and Volatility Ahead of Key Clinical Data
Via MarketMinute
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Syndax Gains Attention With Strong Drug Portfolio, Path To Leukemia Market Growth
Via Benzinga
This HubSpot Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Via Benzinga
Evolv Technologies, Precigen, Hesai Group And Other Big Stocks Moving Higher On Friday
Via Benzinga
Kura (KURA) Revenue Drops 61%
Via The Motley Fool
Excelerate Energy, MediaAlpha And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Here’s Why Shuttle Pharma is the Most Undervalued Biotech Stock in Our Coverage Universe
Via Stocktwits
Kura Oncology Cancer Study Hits Primary Goal, Lays Out Plans For Phase 3 Studies
Via Benzinga
These stocks are moving in today's after hours session
Via Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Nasdaq Edges Higher; Baidu Shares Fall After Q3 Results
Via Benzinga
Crude Oil Gains 1%; Deere Posts Better-Than-Expected Earnings
Via Benzinga
Dow Jumps Over 100 Points; Nvidia Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Kura Oncology Slams The Door On Its Takeover Narrative, And Shares Collapse 26%
Via Investor's Business Daily

Frequently Asked Questions

Is Kura Oncology, Inc. - Common Stock publicly traded?
Yes, Kura Oncology, Inc. - Common Stock is publicly traded.
What exchange does Kura Oncology, Inc. - Common Stock trade on?
Kura Oncology, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Kura Oncology, Inc. - Common Stock?
The ticker symbol for Kura Oncology, Inc. - Common Stock is KURA on the Nasdaq Stock Market
What is the current price of Kura Oncology, Inc. - Common Stock?
The current price of Kura Oncology, Inc. - Common Stock is 9.860
When was Kura Oncology, Inc. - Common Stock last traded?
The last trade of Kura Oncology, Inc. - Common Stock was at 11/07/25 04:00 PM ET
What is the market capitalization of Kura Oncology, Inc. - Common Stock?
The market capitalization of Kura Oncology, Inc. - Common Stock is 674.80M
How many shares of Kura Oncology, Inc. - Common Stock are outstanding?
Kura Oncology, Inc. - Common Stock has 675M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.